Abstract
Adverse drug reaction (ADR) under-reporting is a limitation of pharmacovigilance systems and is predominantly observed in developing countries. Our goal was to find the differences in knowledge, attitude, and perceived barriers of ADR reporting by hospital pharmacists in Pakistan vs USA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have